Johnson & Johnson Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Johnson & Johnson (JNJ) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 6.80 million shares for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-23
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-28 was 6.80M shares, a 89.74% decline year-over-year.
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-29 was 3.50M shares, a 94.25% decline year-over-year.
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-28 was 0.00 shares, a 100.00% decline year-over-year.
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-29 was 66.30M shares, a 91828154.85% increase year-over-year.
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 54.10 shares, a 25.81% increase from fiscal 2023.
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 43.00 shares, a 0.00% change from fiscal 2023.
- Johnson & Johnson antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 43.00 shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | 6.80M shares 10-Q · filed 2026-07-23 | 5.10M shares 10-Q · filed 2026-07-23 | ||||||
| 2026-03-29 | 3.50M shares 10-Q · filed 2026-04-22 | |||||||
| 2025-12-28 | 0.00 shares 10-K · filed 2026-02-11 | |||||||
| 2025-09-28 | 0.00 shares 10-Q · filed 2025-10-22 | 38.80 shares 10-Q · filed 2025-10-22 | ||||||
| 2025-06-29 | 66.30M shares 10-Q · filed 2026-07-23 | 66.30 shares 10-Q · filed 2025-07-24 | 63.30M shares 10-Q · filed 2026-07-23 | 63.30 shares 10-Q · filed 2025-07-24 | ||||
| 2025-03-30 | 60.90M shares 10-Q · filed 2026-04-22 | 60.90 shares 10-Q · filed 2025-04-23 | ||||||
| 2024-12-29 | 54.10 shares 10-K · filed 2026-02-11 | |||||||
| 2024-09-29 | 43.00 shares 10-Q · filed 2025-10-22 | 54.20 shares 10-Q · filed 2025-10-22 | ||||||
| 2024-06-30 | 72.20 shares 10-Q · filed 2025-07-24 | 53.80 shares 10-Q · filed 2025-07-24 | ||||||
| 2024-03-31 | 44.20 shares 10-Q · filed 2025-04-23 | 44.20M shares 10-Q · filed 2024-05-01 | ||||||
| 2023-12-31 | 43.00 shares 10-K · filed 2025-02-13 | 43.00M shares 10-K · filed 2024-02-16 | ||||||
| 2023-10-01 | 16.40 shares 10-Q · filed 2024-10-23 | 16.40M shares 10-Q · filed 2023-10-27 | 42.90 shares 10-Q · filed 2024-10-23 | 42.90M shares 10-Q · filed 2023-10-27 | ||||
| 2023-07-02 | 50.80 shares 10-Q · filed 2024-07-25 | 50.80M shares 10-Q · filed 2023-07-31 | 46.80 shares 10-Q · filed 2024-07-25 | 46.80M shares 10-Q · filed 2023-07-31 | ||||
| 2023-01-01 | 43.00 shares 10-K · filed 2026-02-11 | |||||||
| 2022-01-02 | 0.00 shares 10-K · filed 2025-02-13 | |||||||
| 2021-07-04 | 14.00M shares 10-Q · filed 2022-07-29 | |||||||
| 2021-04-04 | 9.00M shares 10-Q · filed 2022-04-29 | |||||||
| 2021-01-03 | 18.00M shares 10-K · filed 2023-02-16 | |||||||
| 2020-09-27 | 20.00M shares 10-Q · filed 2021-10-29 | 17.00M shares 10-Q · filed 2021-10-29 | ||||||
| 2020-06-28 | 20.00M shares 10-Q · filed 2021-07-29 | 15.00M shares 10-Q · filed 2021-07-29 | ||||||
| 2020-03-29 | 10.00M shares 10-Q · filed 2021-04-30 | |||||||
| 2019-09-29 | 19.00M shares 10-Q · filed 2020-10-23 | |||||||
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-04-29 | |||||||
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-10-28 | 0.00 shares 10-Q · filed 2019-10-28 | ||||||
| 2018-07-01 | 17.00M shares 10-Q · filed 2019-07-29 | 0.00 shares 10-Q · filed 2019-07-29 | ||||||
| 2018-04-01 | 0.00 shares 10-Q · filed 2019-05-01 | |||||||
| 2017-10-01 | 0.00 shares 10-Q · filed 2018-10-31 | 0.00 shares 10-Q · filed 2018-10-31 | ||||||
| 2017-07-02 | 0.00 shares 10-Q · filed 2018-08-02 | 0.00 shares 10-Q · filed 2018-08-02 | ||||||
| 2017-04-02 | 0.00 shares 10-Q · filed 2018-05-01 | |||||||
| 2016-10-02 | 0.00 shares 10-Q · filed 2017-11-02 | 0.00 shares 10-Q · filed 2017-11-02 | ||||||
| 2016-07-03 | 0.00 shares 10-Q · filed 2017-08-03 | 0.00 shares 10-Q · filed 2017-08-03 | ||||||
| 2016-04-03 | 0.00 shares 10-Q · filed 2017-05-08 | |||||||
| 2015-09-27 | 20.00M shares 10-Q · filed 2016-11-04 | 20.00M shares 10-Q · filed 2016-11-04 | ||||||
| 2015-06-28 | 0.00 shares 10-Q · filed 2015-07-31 | |||||||
| 2014-12-28 | 0.00 shares 10-K · filed 2015-02-24 | |||||||
| 2014-06-29 | 9.00K shares 10-Q · filed 2015-07-31 | |||||||
| 2013-12-29 | 0.00 shares 10-K · filed 2015-02-24 | |||||||
| 2012-12-30 | 200.00K shares 10-K · filed 2015-02-24 | |||||||
| 2012-09-30 | 1.00M shares 10-Q · filed 2013-11-04 | |||||||
| 2012-07-01 | 57.00M shares 10-Q · filed 2013-08-01 | 57.00M shares 10-Q · filed 2013-08-01 | ||||||
| 2012-04-01 | 50.00M shares 10-Q · filed 2013-05-03 | |||||||
| 2012-01-01 | 50.70M shares 10-K · filed 2014-02-21 | 51.00M shares 10-K · filed 2012-02-23 | ||||||
| 2011-10-02 | 51.00M shares 10-Q · filed 2012-11-09 | 51.00M shares 10-Q · filed 2012-11-09 | ||||||
| 2011-07-03 | 51.00M shares 10-Q · filed 2012-08-02 | 52.00M shares 10-Q · filed 2012-08-02 | ||||||
| 2011-04-03 | 93.00M shares 10-Q · filed 2012-05-07 | |||||||
| 2011-01-02 | 66.30M shares 10-K · filed 2013-02-22 | 66.00M shares 10-K · filed 2011-02-25 | ||||||
| 2010-10-03 | 86.00M shares 10-Q · filed 2011-11-08 | 85.00M shares 10-Q · filed 2011-11-08 | ||||||
| 2010-07-04 | 68.00M shares 10-Q · filed 2011-08-09 | 68.00M shares 10-Q · filed 2011-08-09 | ||||||
| 2010-04-04 | 55.00M shares 10-Q · filed 2011-05-10 | |||||||
| 2010-01-03 | 121.00M shares 10-K · filed 2012-02-23 | |||||||
| 2009-09-27 | 77.00M shares 10-Q · filed 2010-11-10 | 148.00M shares 10-Q · filed 2010-11-10 | ||||||
| 2009-06-28 | 178.00M shares 10-Q · filed 2010-08-11 | 151.00M shares 10-Q · filed 2010-08-11 | ||||||
| 2008-12-28 | 59.00M shares 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |